Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

NENCA Study on Neurological Complications of Long COVID-19 in Children and Adolescents; Neurophysiological, Electroencephalographic and Neuroradiological Investigation

  • Read more about NENCA Study on Neurological Complications of Long COVID-19 in Children and Adolescents; Neurophysiological, Electroencephalographic and Neuroradiological Investigation

Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome

  • Read more about Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

  • Read more about Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Bedside Assessment of Immune Function in Patients With Covid-19

  • Read more about Bedside Assessment of Immune Function in Patients With Covid-19

Infant Malaria Vaccine Schedule Optimization

  • Read more about Infant Malaria Vaccine Schedule Optimization

Vima Therapeutics

By jpalfreyman on Mon, 03/17/2025 - 11:31
  • Read more about Vima Therapeutics

Medregen LLC

By jpalfreyman on Fri, 03/14/2025 - 13:36
  • Read more about Medregen LLC

Clinical Leader: Trends In FDA FY 2024 Inspection-Based Warning Letters

Importantly, on October 1, 2024, the FDA implemented a long-planned reorganization of the Human Foods Program and the FDA field operations in response to the Reagan-Udall Foundation Evaluation published in 2022.
Coverage
  • Read more about Clinical Leader: Trends In FDA FY 2024 Inspection-Based Warning Letters

Evaluating the Impact of a Functional and Cognitive Strategy in Patients with Long Covid-19

  • Read more about Evaluating the Impact of a Functional and Cognitive Strategy in Patients with Long Covid-19

Assessment of Vertigo and Dizziness in Individuals Following COVID-19

  • Read more about Assessment of Vertigo and Dizziness in Individuals Following COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA